• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小冠状动脉内支架再狭窄:支架厚度的影响

In-stent restenosis in small coronary arteries: impact of strut thickness.

作者信息

Briguori Carlo, Sarais Cristiano, Pagnotta Paolo, Liistro Francesco, Montorfano Matteo, Chieffo Alaide, Sgura Fabio, Corvaja Nicola, Albiero Remo, Stankovic Goran, Toutoutzas Costantinos, Bonizzoni Erminio, Di Mario Carlo, Colombo Antonio

机构信息

Laboratory of Interventional Cardiology, Vita e Salute University School of Medicine, San Raffaele Hospital, Milan, Italy.

出版信息

J Am Coll Cardiol. 2002 Aug 7;40(3):403-9. doi: 10.1016/s0735-1097(02)01989-7.

DOI:10.1016/s0735-1097(02)01989-7
PMID:12142103
Abstract

UNLABELLED

OBJECTIVES; We sought to evaluate whether strut thickness may impact the restenosis rate after stent implantation in small coronary arteries.

BACKGROUND

Small vessel size (<3.0 mm) is an independent risk factor for the occurrence of in-stent restenosis. It has been reported that vessel damage induced during stent deployment is an important factor in restenosis.

METHODS

From our database, we selected all patients who had successful stenting in small native vessels, with angiographic follow-up available, between March 1996 and April 2001. The strut was defined as thin when <0.10 mm and thick when > or = 0.10 mm. According to these criteria, we identified two subgroups: a thin group and a thick group.

RESULTS

A total of 821 (57%) of the 1,447 patients had angiographic follow-up available and were included in the analysis. The thin group included 400 patients with 505 lesions. The thick group included 421 patients with 436 lesions. The restenosis rate was 28.5% in the thin group and 36.6% in the thick group (p = 0.009; odds ratio [OR] 1.44, 95% confidence interval [CI] 1.09 to 1.90). The study group was classified into three subgroups according to the reference vessel diameter: < or = 2.50 mm, 2.51 to 2.75 mm and 2.76 to 2.99 mm. Strut thickness influenced the restenosis rate only in the subgroup with a reference vessel diameter between 2.76 and 2.99 mm, with rates of 23.5% in the thin group and 37% in the thick group (p = 0.006). By logistic regression analysis, predictors of restenosis were stent length (OR 1.03, 95% CI 1.01 to 1.04; p = 0.001), strut thickness (OR 1.68, 95% CI 1.23 to 2.29; p = 0.001) and diabetes mellitus (OR 2.10, 95% CI 1.21 to 3.68; p = 0.007).

CONCLUSIONS

This study supports that strut thickness is an independent predictor of restenosis in coronary arteries with a reference diameter of 2.75 to 2.99 mm.

摘要

未标注

目的;我们试图评估支架小梁厚度是否会影响小冠状动脉支架植入术后的再狭窄率。

背景

小血管直径(<3.0毫米)是支架内再狭窄发生的独立危险因素。据报道,支架置入过程中引起的血管损伤是再狭窄的一个重要因素。

方法

从我们的数据库中,我们选择了1996年3月至2001年4月期间在小的自身血管中成功进行支架置入且有血管造影随访资料的所有患者。当支架小梁厚度<0.10毫米时定义为薄,当≥0.10毫米时定义为厚。根据这些标准,我们确定了两个亚组:薄组和厚组。

结果

1447例患者中有821例(57%)有血管造影随访资料并纳入分析。薄组包括400例患者和505处病变。厚组包括421例患者和436处病变。薄组的再狭窄率为28.5%,厚组为36.6%(p = 0.009;优势比[OR]1.44,95%置信区间[CI]1.09至1.90)。根据参照血管直径,研究组分为三个亚组:≤2.50毫米、2.51至2.75毫米和2.76至2.99毫米。支架小梁厚度仅在参照血管直径为2.76至2.99毫米的亚组中影响再狭窄率,薄组的再狭窄率为23.5%,厚组为37%(p = 0.006)。通过逻辑回归分析,再狭窄的预测因素为支架长度(OR 1.03,95% CI 1.01至1.04;p = 0.001)、支架小梁厚度(OR 1.68,95% CI 1.23至2.29;p = 0.001)和糖尿病(OR 2.10,95% CI 1.21至3.68;p = 0.007)。

结论

本研究支持支架小梁厚度是参照直径为2.75至2.99毫米的冠状动脉再狭窄的独立预测因素。

相似文献

1
In-stent restenosis in small coronary arteries: impact of strut thickness.小冠状动脉内支架再狭窄:支架厚度的影响
J Am Coll Cardiol. 2002 Aug 7;40(3):403-9. doi: 10.1016/s0735-1097(02)01989-7.
2
Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial.冠状动脉内支架置入术与血管造影结果:支架厚度对再狭窄结局的影响(ISAR-STEREO)试验
Circulation. 2001 Jun 12;103(23):2816-21. doi: 10.1161/01.cir.103.23.2816.
3
[Intracoronary Stenting and Angiographic Results Strut Thickness Effect on Restenosis Outcome (ISAR-STEREO) Trial].冠状动脉内支架置入术及血管造影结果:支架小梁厚度对再狭窄结局的影响(ISAR-STEREO)试验
Vestn Rentgenol Radiol. 2012 Mar-Apr(2):52-60.
4
Vessel caliber and restenosis: a prospective clinical and angiographic study of NIR stent deployment in small and large coronary arteries in the same patient.血管管径与再狭窄:同一患者冠状动脉大小血管中近红外支架植入的前瞻性临床与血管造影研究
Catheter Cardiovasc Interv. 2003 Jun;59(2):165-71. doi: 10.1002/ccd.10502.
5
Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial.冠状动脉内支架置入术及血管造影结果:支架厚度对再狭窄结局的影响(ISAR-STEREO-2)试验
J Am Coll Cardiol. 2003 Apr 16;41(8):1283-8. doi: 10.1016/s0735-1097(03)00119-0.
6
Long-term clinical outcome after implantation of medium Palmaz (biliary) stents in very large native coronary arteries.在非常粗大的自身冠状动脉中植入中型帕尔马兹(胆道)支架后的长期临床结果。
Catheter Cardiovasc Interv. 2002 May;56(1):35-9. doi: 10.1002/ccd.10177.
7
Impact of lesion complexity on the capacity of a trial to detect differences in stent performance: results from the ISAR-STEREO trial.病变复杂性对检测支架性能差异的试验能力的影响:来自ISAR-STEREO试验的结果
Am Heart J. 2003 Nov;146(5):882-6. doi: 10.1016/S0002-8703(03)00435-6.
8
Comparison of clinical outcomes using stents versus no stents after percutaneous coronary intervention for proximal left anterior descending versus proximal right and left circumflex coronary arteries.经皮冠状动脉介入治疗近端左前降支与近端右冠状动脉及左旋支冠状动脉后使用支架与不使用支架的临床结局比较。
Am J Cardiol. 2002 May 15;89(10):1162-6. doi: 10.1016/s0002-9149(02)02297-x.
9
Factors predictive of cardiac events and restenosis after sirolimus-eluting stent implantation in small coronary arteries.小冠状动脉中雷帕霉素洗脱支架植入术后心脏事件和再狭窄的预测因素。
Catheter Cardiovasc Interv. 2007 May 1;69(6):821-5. doi: 10.1002/ccd.21019.
10
Thin-strut drug-eluting stents are more favorable for severe calcified lesions after rotational atherectomy than thick-strut drug-eluting stents.对于旋磨术后的严重钙化病变,薄支柱药物洗脱支架比厚支柱药物洗脱支架更具优势。
J Invasive Cardiol. 2014 Feb;26(2):41-5.

引用本文的文献

1
Polymer-Free Versus Biodegradable Polymer Drug-Eluting Stents in Coronary Artery Disease: Updated Systematic Review and Meta-Analysis of Clinical, Angiographic, and OCT Outcomes.冠状动脉疾病中无聚合物与可生物降解聚合物药物洗脱支架的比较:临床、血管造影及光学相干断层扫描结果的最新系统评价和荟萃分析
Biomedicines. 2025 Jun 14;13(6):1470. doi: 10.3390/biomedicines13061470.
2
Everolimus-eluting versus biolimus-eluting stents with biodegradable polymers in unselected patients undergoing percutaneous coronary intervention: five-year results of the randomised, non-inferiority SORT OUT VIII trial.在接受经皮冠状动脉介入治疗的未选择患者中,依维莫司洗脱支架与含可生物降解聚合物的生物雷帕霉素洗脱支架对比:随机、非劣效性SORT OUT VIII试验的五年结果
EuroIntervention. 2025 Jun 2;21(11):e629-e638. doi: 10.4244/EIJ-D-24-00763.
3
From Mechanisms to Management: Tackling In-Stent Restenosis in the Drug-Eluting Stent Era.从机制到管理:应对药物洗脱支架时代的支架内再狭窄
Curr Cardiol Rep. 2025 Feb 11;27(1):53. doi: 10.1007/s11886-025-02193-z.
4
Drug-coated balloons versus drug-eluting stents in patients with in-stent restenosis: An updated meta-analysis with trial sequential analysis.药物涂层球囊与药物洗脱支架治疗支架内再狭窄患者的疗效比较:一项更新的荟萃分析与试验序贯分析。
J Cardiothorac Surg. 2024 Nov 6;19(1):624. doi: 10.1186/s13019-024-03046-6.
5
A Meta-Analysis of 3-Year Outcomes of Drug-Coated Balloons Versus Drug-Eluting Stents for Small-Vessel Coronary Artery Disease.药物涂层球囊与药物洗脱支架治疗小血管冠状动脉疾病3年预后的Meta分析。
JACC Adv. 2024 Aug 19;3(10):101204. doi: 10.1016/j.jacadv.2024.101204. eCollection 2024 Oct.
6
Drug-coated balloon: an effective alternative to stent strategy in small-vessel coronary artery disease-a meta-analysis.药物涂层球囊:小血管冠状动脉疾病中支架策略的有效替代方案——一项荟萃分析
Front Cardiovasc Med. 2023 Aug 21;10:1213992. doi: 10.3389/fcvm.2023.1213992. eCollection 2023.
7
Evaluation of a Rabbit Model of Vascular Stent Healing: Application of Optical Coherence Tomography.血管支架愈合兔模型的评估:光学相干断层扫描的应用
J Cardiovasc Transl Res. 2023 Oct;16(5):1194-1204. doi: 10.1007/s12265-023-10399-1. Epub 2023 May 25.
8
Fully implantable wireless batteryless vascular electronics with printed soft sensors for multiplex sensing of hemodynamics.具有用于血流动力学多重传感的印刷软传感器的完全植入式无线无电池血管电子设备。
Sci Adv. 2022 May 13;8(19):eabm1175. doi: 10.1126/sciadv.abm1175. Epub 2022 May 11.
9
Elastic stent recoil in coronary total occlusions: Comparison of durable-polymer zotarolimus eluting stent and ultrathin strut bioabsorbable-polymer sirolimus eluting stent.冠状动脉完全闭塞中弹性支架回缩:持久聚合物佐他莫司洗脱支架和超薄支架生物可吸收聚合物西罗莫司洗脱支架的比较。
Catheter Cardiovasc Interv. 2022 Jan 1;99(1):88-97. doi: 10.1002/ccd.29739. Epub 2021 May 7.
10
Ultrathin (60 μm), ultralong (≥40 mm) sirolimus-eluting stent: study of clinical and safety profiles among real-world patients.超薄(60μm)、超长(≥40mm)西罗莫司洗脱支架:真实世界患者临床和安全性特征研究。
Anatol J Cardiol. 2021 Feb;25(2):111-119. doi: 10.14744/AnatolJCardiol.2020.40909.